A Study to Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558

NCT05685719 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

DRUG: STI-1558
DRUG: Itraconazole
DRUG: Rifampin

Sponsor

Zhejiang ACEA Pharmaceutical Co. Ltd.